The therapeutic effect was associated with marked distant tumor infiltration with activated CD8+ and CD4+ effector but not with regulatory T cells, and was dependent on CD8+ T cells, NK cells, and type I interferon. The gene discussed is CD8A; the disease is neoplasm.